Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis
- PMID: 28330887
- PMCID: PMC5442530
- DOI: 10.1128/JCM.02497-16
Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis
Abstract
We evaluated the usefulness of an Aspergillus galactomannan (GM) test, a β-d-glucan (βDG) test, and two different Aspergillus PCR assays of bronchoalveolar lavage fluid (BALF) samples for the diagnosis of chronic pulmonary aspergillosis (CPA). BALF samples from 30 patients with and 120 patients without CPA were collected. We calculated the sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio for each test individually and in combination with other tests. The optical density index values, as determined by receiver operating characteristic analysis, for the diagnosis of CPA were 0.5 and 100 for GM and βDG testing of BALF, respectively. The sensitivity and specificity of the GM test, βDG test, and PCR assays 1 and 2 were 77.8% and 90.0%, 77.8% and 72.5%, 86.7% and 84.2%, and 66.7% and 94.2%, respectively. A comparison of the PCR assays showed that PCR assay 1 had a better sensitivity, a better negative predictive value, and a better negative likelihood ratio and PCR assay 2 had a better specificity, a better positive predictive value, and a better positive likelihood ratio. The combination of the GM and βDG tests had the highest diagnostic odds ratio. The combination of the GM and βDG tests on BALF was more useful than any single test for diagnosing CPA.
Keywords: Aspergillus PCR assays; Aspergillus galactomannan test; chronic pulmonary aspergillosis; β-d-glucan test.
Copyright © 2017 American Society for Microbiology.
Figures
Similar articles
-
Detection of Aspergillus DNA in BALF by Real-time PCR and Galactomannan Antigen for the Early Diagnosis of Chronic Pulmonary Aspergillosis.Ann Clin Lab Sci. 2021 Sep;51(5):698-704. Ann Clin Lab Sci. 2021. PMID: 34686513
-
Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.J Clin Microbiol. 2014 Jun;52(6):2039-45. doi: 10.1128/JCM.00467-14. Epub 2014 Mar 26. J Clin Microbiol. 2014. PMID: 24671798 Free PMC article.
-
Utility of Serum and Bronchoalveolar Lavage Fluid Galactomannan in Diagnosis of Chronic Pulmonary Aspergillosis.J Clin Microbiol. 2019 Feb 27;57(3):e01821-18. doi: 10.1128/JCM.01821-18. Print 2019 Mar. J Clin Microbiol. 2019. PMID: 30626661 Free PMC article.
-
The performance of galactomannan in combination with 1,3-β-D-glucan or aspergillus-lateral flow device for the diagnosis of invasive aspergillosis: Evidences from 13 studies.Diagn Microbiol Infect Dis. 2019 Jan;93(1):44-53. doi: 10.1016/j.diagmicrobio.2018.08.005. Epub 2018 Aug 18. Diagn Microbiol Infect Dis. 2019. PMID: 30279025
-
How to make a fast diagnosis in invasive aspergillosis.Med Mycol. 2019 Apr 1;57(Supplement_2):S155-S160. doi: 10.1093/mmy/myy103. Med Mycol. 2019. PMID: 30816965 Review.
Cited by
-
Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis.Front Microbiol. 2018 Aug 17;9:1810. doi: 10.3389/fmicb.2018.01810. eCollection 2018. Front Microbiol. 2018. PMID: 30174658 Free PMC article. Review.
-
Chronic Pulmonary Aspergillosis: Notes for a Clinician in a Resource-Limited Setting Where There Is No Mycologist.J Fungi (Basel). 2020 Jun 2;6(2):75. doi: 10.3390/jof6020075. J Fungi (Basel). 2020. PMID: 32498415 Free PMC article. Review.
-
False-positive Elevation of Beta-D-glucan and Aspergillus Galactomannan Levels Due to Mendelson's Syndrome after Rice Aspiration.Intern Med. 2022 Oct 1;61(19):2935-2939. doi: 10.2169/internalmedicine.8805-21. Epub 2022 Mar 19. Intern Med. 2022. PMID: 35314546 Free PMC article.
-
Diagnosis of Chronic Pulmonary Aspergillosis: Challenges and Limitations Response to "Diagnosis of Chronic Pulmonary Aspergillosis: Which Is the Best Investigation?" and "Diagnosis of Chronic Pulmonary Aspergillosis".Am J Trop Med Hyg. 2023 Apr 17;108(6):1302-1303. doi: 10.4269/ajtmh.23-0053c. Am J Trop Med Hyg. 2023. PMID: 37068758 Free PMC article. No abstract available.
-
The Utility of Galactomannan and Polymerase Chain Reaction Assays in Bronchoalveolar Lavage for Diagnosis of Chronic Pulmonary Aspergillosis.Mycopathologia. 2023 Dec;188(6):1041-1053. doi: 10.1007/s11046-023-00797-z. Epub 2023 Oct 20. Mycopathologia. 2023. PMID: 37857979
References
-
- Cadranel J, Philippe B, Hennequin C, Bergeron A, Bergot E, Bourdin A, Cottin V, Jeanfaivre T, Godet C, Pineau M, Germaud P. 2012. Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial. Eur J Clin Microbiol Infect Dis 31:3231–3239. doi:10.1007/s10096-012-1690-y. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical